Anne Wojcicki, 23andMe CEO (Jordan Vonderhaar/Bloomberg via Getty Images)
October 1, 2024 09:46 AM EDTUpdated 10:15 AM
Financing
Deals
Health Tech

23andMe CEO says she is no longer open to out­side takeover of­fers

Ngai Yeung

23andMe CEO Anne Wo­j­ci­c­ki has said she is no longer open to con­sid­er­ing oth­er buy­ers for the com­pa­ny in a

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J and Bay­er to lay off al­most 300 staffers in New Jer­sey

Ron Re­naud's new obe­si­ty biotech, Kail­era, has $400M to go straight to Phase 3

GSK’s Vi­iV stops de­vel­op­ment of Phase 2 HIV an­tivi­ral

Judge keeps Am­gen's $10.7B tax li­a­bil­i­ty suit alive 

CVS con­sid­ers break­ing up the com­pa­ny as in­vestors urge turn­around — re­ports

sponsored

3 Tiers for AAV Po­ten­cy As­say De­vel­op­ment Suc­cess

A service from the Financial Times